Residual Symptoms After Coronavirus Disease (COVID-19) in Lithuanian Population

• Conditions: Post-Covid Syndrome

• Registration Number: NCT05000229
• Lead Sponsor: Lithuanian University of Health Sciences

Brief Summary

The aim of the study is to describe the post-covid-19 syndrome in Lithuanian population regarding the remaining symptoms and their impact on physical functioning, work ability and needs of rehabilitation.

Detailed Description

Participants with suspected and confirmed cases of COVID-19 infection will complete an anonymous online questionnaire for post-covid syndrome, i.e. symptoms lasting longer than 28 days after post-covid-19 syndrome. The online survey is developed to assess the health state before infection and residual symptoms lasting longer than acute COVID-19 infection, influencing the functional activity and work ability. The needs of rehabilitation will also be assessed.

Study Timeline

• Study Start: 2021-05-04
• Study First Submitted: 2021-07-16
• Status Verified: 2021-08
• Study First Submitted QC: 2021-08-10
• Last Update Submitted: 2021-08-10
• Study First Posted: 2021-08-11
• Last Update Posted: 2021-08-11
• Primary Completion: 2022-12-31
• Study Completion: 2022-12-31

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 5000

Inclusion Criteria

• older than 18 years age patients;
• a history of COVID-19 infection that was and was not positive for SARS-CoV-2 diagnostic or antibody testing
• the duration of remaining symptoms is longer than 28 days
• ability to fulfil internet-based questionnaire

Exclusion Criteria

• ongoing covid-19 infection
• other comorbidities requiring treatment or rehabilitation

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Description of post-covid-19 syndrome in Lithuanian population	2021.05.04 - 2022.12.31	Post-covid-19 syndrome in Lithuanian population: prevalence, symptomatology and needs of rehabilitation

Secondary Outcome Measures

Name	Time	Method
Assessment of medical premorbid status in post-covid-19 syndrome	2021.05.04 - 2022.12.31	The severity of comorbidities in terms of self-reported medical diagnoses and medication

Trial Locations

Locations (1)

Lithuanian University of Health Sciences; 🇱🇹 Kaunas, Lithuania